Paras Healthcare Q2 Results 2026: PAT ₹40 Cr, Revenue ₹511 Cr
Q2 FY27 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹511Cr
- Net profit
- ₹40Cr
- Margin
- 23.5%
What the Q2 FY27 call signalled
3 of 3 strong
The short version
Paras Healthcare expects strong revenue growth driven by ramp-up of newer hospitals transitioning from new to emerging and then to mature cohorts.
From Paras Healthcare Ltd's Q2 FY27 earnings-call transcript · updated 13 Nov 2026.
How did Paras Healthcare's revenue grow in the September 2026 quarter?
- Paras Healthcare expects strong revenue growth driven by ramp-up of newer hospitals transitioning from new to emerging and then to mature cohorts.
- Occupancy improvements noted across cohorts: mature hospitals around 76.5%, emerging hospitals about 68.6%, and new hospitals showing rapid growth in occupancies.
- Volume growth strong with inpatient volumes up 27.3% and outpatient volumes up 20.4% year-on-year.
- ARPOB (Average Revenue Per Occupied Bed) and specialty case mix improvements expected to contribute to revenue enhancement.
2 more points from Paras Healthcare Ltd's call on revenue
Create a free account to keep reading this call
What happened to Paras Healthcare's margins in Q2 FY27?
See what Paras Healthcare Ltd said on profitability & margins — free account, 30 seconds.
What capex is Paras Healthcare planning?
- Half-year Capex for H1 FY27 was INR 90 crores, invested across various units and payments for the new Gurgaon 2 unit.
- Future capital investments include commissioning:
- Gurgaon hospital (Golf Course Extension) with 300 beds by year-end.
- Ludhiana hospital with 500 beds planned for next year.
- New hospital bed operationalization planned: 200-250 beds to be opened in Kanpur and Ranchi soon, increasing operational beds from 1,500 to ~1,800.
- Expansion strategy focuses on asset-light models for new hospitals including Gurgaon and Ludhiana.
2 more points from Paras Healthcare Ltd's call on capex
Create a free account to keep reading this call
Is Paras Healthcare raising money or cutting debt?
See what Paras Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Paras Healthcare's order book?
See what Paras Healthcare Ltd said on order book & pipeline — free account, 30 seconds.
Paras Healthcare Ltd — Quarterly revenue & net profit
Paras Healthcare Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 511 |
| Operating profit (EBITDA) | 120 |
| Operating margin | 23.5% |
| Profit before tax | 54 |
| Net profit (PAT) | 40 |
| EPS (₹) | 4.00 |
Source: Paras Healthcare Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹511 Cr, net profit ₹40 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Paras Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Paras Healthcare Ltd Q2 FY27 results?
Paras Healthcare reported net profit of ₹40 Cr on revenue of ₹511 Cr in Q2 FY27.
What is Paras Healthcare Ltd share price analysis?
Paras Healthcare Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 141.2 with a market cap of ₹10,125 Cr. Investors should review the full earnings analysis for detailed insights.
Is Paras Healthcare Ltd planning capital expenditure?
Half-year Capex for H1 FY27 was INR 90 crores, invested across various units and payments for the new Gurgaon 2 unit.
Keep Paras Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
